| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
103,570,000 | 94,827,000 | 97,690,000 | 96,773,000 | 81,462,000 |
| Cost of Revenue
|
-83,596,000 | -77,733,000 | -80,240,000 | -79,113,000 | -60,609,000 |
|
Gross Profit
|
19,974,000 | 17,094,000 | 17,450,000 | 17,660,000 | 20,853,000 |
|
Selling, General and Administrative Expenses
|
-7,485,000 | -5,834,000 | -5,150,000 | -4,800,000 | -3,946,000 |
|
Research and Development Expenses
|
-8,861,000 | -6,411,000 | -4,540,000 | -3,969,000 | -3,075,000 |
|
Operating Income/Expenses
|
-16,346,000 | -12,245,000 | -9,690,000 | -8,769,000 | -7,021,000 |
|
Total Operating Profit/Loss
|
3,628,000 | 4,849,000 | 7,760,000 | 8,891,000 | 13,832,000 |
| Total Net Finance Income/Expense
|
1,402,000 | 1,342,000 | 1,219,000 | 910,000 | 106,000 |
| Irregular Income/Expenses
|
-162,000 | -494,000 | -684,000 | 0 | -176,000 |
|
Other Income/Expense, Non-Operating
|
-654,000 | -419,000 | 695,000 | 172,000 | -43,000 |
|
Non-Operating Income/Expenses, Total
|
586,000 | 429,000 | 1,230,000 | 1,082,000 | -113,000 |
|
Pretax Income
|
4,214,000 | 5,278,000 | 8,990,000 | 9,973,000 | 13,719,000 |
|
Provision for Income Tax
|
-935,000 | -1,423,000 | -1,837,000 | 5,001,000 | -1,132,000 |
|
Net Income from Continuing Operations
|
3,279,000 | 3,855,000 | 7,153,000 | 14,974,000 | 12,587,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,279,000 | 3,855,000 | 7,153,000 | 14,974,000 | 12,587,000 |
|
Non-Controlling/Minority Interests
|
-61,000 | -61,000 | -23,000 | 25,000 | -4,000 |
|
Net Income after Non-Controlling/Minority Interests
|
3,218,000 | 3,794,000 | 7,130,000 | 14,999,000 | 12,583,000 |
|
Other Adjustments to Net Income Available to Common Stockholders
|
2,000 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
3,220,000 | 3,794,000 | 7,130,000 | 14,999,000 | 12,583,000 |
|
Dilution to Earnings
|
0 | -- | 0 | 0 | 1,000 |
|
Diluted Net Income Available to Common Stockholders
|
3,220,000 | 3,794,000 | 7,130,000 | 14,999,000 | 12,584,000 |
| Basic EPS
|
1.00 | 1.18 | 2.23 | 4.73 | 4.02 |
| Diluted EPS
|
0.91 | 1.08 | 2.04 | 4.30 | 3.62 |
|
Basic Weighted Average Shares Outstanding
|
3,235,500 | 3,225,000 | 3,197,000 | 3,174,000 | 3,130,000 |
|
Diluted Weighted Average Shares Outstanding
|
3,540,000 | 3,528,000 | 3,498,000 | 3,485,000 | 3,475,000 |
|
Reported Normalized Diluted EPS
|
1.81 | 1.66 | 2.42 | 3.12 | -- |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
2,812,000 | 3,936,000 | 7,771,000 | 9,063,000 | 13,613,000 |
|
EBITDA
|
9,516,000 | 10,084,000 | 13,139,000 | 13,730,000 | 17,360,000 |
|
Normalized EBITDA
|
15,450,000 | 14,596,000 | 16,056,000 | 16,631,000 | 19,494,000 |
12/31/2022 - 10/25/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade